Using image guided platforms with three-dimensional treatment simulators for treatment planning and execution, the department provides extensive brachytherapy services including all facets of genitourinary and gynecological applications to patients.
The Department of Radiation Oncology houses IROC Rhode Island (QARC), a research program providing quality assurance and data management services for diagnostic imaging and radiation therapy for the NCI's National Clinical Trials Network (NCTN). Led by Dr. FitzGerald as its director and principal investigator, QARC acquires and reviews imaging and radiation treatment objects to ensure compliance with protocol guidelines for patients on clinical trials. QARC is located in Lincoln, RI.
The department has several research interests, with particular emphasis on signaling pathways and cellular adhesion molecules. Most of the targeted oncology therapies developed in the past five years include tyrosine kinase-based therapies that sensitize cancer cells to radiation therapy. Identifying the interactions between these therapies and radiation therapy is the focus of the translational research effort, with collaborations promoted through the departments of Cancer Biology and Cell Biology.
Thomas (TJ) FitzGerald, MD
Christopher Riberdy, MHA, BS, RTT
Director Radiation Oncology
UMMMG Cancer Services Administrator
Executive Administrative Assistant